Kepler Cheuvreux re-initiated coverage of Aperam (APEMY) with a Buy rating and EUR 31.10 price target The company has become “much stronger” through its diversification efforts, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY:
- Aperam price target lowered to EUR 29.60 from EUR 30.10 at Morgan Stanley
- Aperam Reports Challenging Q1 2025 Financial Results
- Aperam’s Strategic Growth and Sustainability Focus in Q1 2025 Earnings Call
- APEMY Upcoming Earnings Report: What to Expect?
- Aperam price target lowered to EUR 38 from EUR 40 at Deutsche Bank